Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) Gross Margin (2018 - 2025)

AVITA Medical filings provide 8 years of Gross Margin readings, the most recent being 15.56% for Q4 2025.

  • On a quarterly basis, Gross Margin fell 7380.0% to 15.56% in Q4 2025 year-over-year; TTM through Dec 2025 was 40.29%, a 4625.0% decrease, with the full-year FY2025 number at 82.98%, down 335.0% from a year prior.
  • Gross Margin hit 15.56% in Q4 2025 for AVITA Medical, down from 81.32% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 89.35% in Q4 2024 to a low of 15.56% in Q4 2025.
  • Median Gross Margin over the past 5 years was 84.27% (2023), compared with a mean of 79.54%.
  • Biggest five-year swings in Gross Margin: surged 778bps in 2023 and later crashed -7380bps in 2025.
  • AVITA Medical's Gross Margin stood at 84.5% in 2021, then increased by 1bps to 85.75% in 2022, then grew by 2bps to 87.35% in 2023, then grew by 2bps to 89.35% in 2024, then crashed by -83bps to 15.56% in 2025.
  • The last three reported values for Gross Margin were 15.56% (Q4 2025), 81.32% (Q3 2025), and 81.17% (Q2 2025) per Business Quant data.